{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T17:42:58Z","timestamp":1695836578306},"reference-count":8,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":4588,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[1996,10]]},"abstract":"<jats:p><jats:bold>Zusammenfassung. <\/jats:bold> Es wurden die MHK\u2010Werte f\u00fcr Fluconazol von 90 <jats:italic>Candida<\/jats:italic>\u2010Isolaten (56 <jats:italic>C. albicans<\/jats:italic>, 15 <jats:italic>C. glabrata<\/jats:italic>, 9 <jats:italic>C. krusei<\/jats:italic> und 10 <jats:italic>C. tropicalis<\/jats:italic>) untersucht. Zur Antimykotika\u2010Resistenztestung wurden die Mikrodilutionsmethoden nach dem Protokoll M27\u2010P des NCCLS (M27\u2010Pmicro) mit RPMI 1640\u2010Medium sowie der Methode nach Troke &amp; Pye mit HR\u2010Medium (HRmicro) als auch die Agardiffusionsmethode mit dem Etest (YNB\u2010Agar) verwendet. Die Ergebnisse mit diesen Methoden wurden mit den klinischen Befunden verglichen. S\u00e4mtliche <jats:italic>C. albicans<\/jats:italic>\u2010Isolate von AIDS\u2010Patienten mit Fluconazol\u2010refrakt\u00e4rer Candidose hatten MHK\u2010Werte entweder \u2265 6,25 \u03bcg\/ml (M27\u2010Pmicro) oder \u2265 25 \u03bcg\/ml (HRmicro und Etest). Andererseits lagen die MHK\u2010Werte von <jats:italic>C. albicans<\/jats:italic>\u2010Isolaten bei AIDS\u2010Patienten mit Fluconazol\u2010empfindlicher Candidose teil\u2010weise ebenfalls \u00fcber diesen Endpunkten. Ein m\u00f6gliches Ansprechen auf eine Fluconazol\u2010Therapie kann somit nicht zwangsl\u00e4ufig von dem MHK\u2010Wert abgeleitet werden.<\/jats:p><jats:p><jats:bold>Summary. <\/jats:bold> The MIC values of fluconazole were determined for 96 <jats:italic>Candida<\/jats:italic> isolates (56 <jats:italic>C. albicans<\/jats:italic>, 15 <jats:italic>C. glabrata<\/jats:italic>, 9 <jats:italic>C. krusei<\/jats:italic> and 10 <jats:italic>C. tropicalis<\/jats:italic>). The methods employed for antifungal susceptibility testing were: microdilution according to the protocol M27\u2010P of the NCCLS (M 27\u2010Pmicro) using RPMI 1640 medium or HR medium following Troke &amp; Pye (HRmicro) as well as the agar diffusion method by means of the Etest (YNB agar). The in vitro results were compared with the clinical outcome of patients. All <jats:italic>C. albicans<\/jats:italic> isolates received from AIDS patients with fluconazole\u2010refractory candidosis showed MICs of \u2265 6,25 mg\/ml (M27\u2010Pmicro) or \u2265 25 mg\/ml (MRmicro) and Etest). On the other hand some MICs of <jats:italic>C. albicans<\/jats:italic> isolates from AIDS patients with fluconazole\u2010sensitive candidosis were also beyond these breakpoints. Therefore a possible success of a fluconazole therapy cannot unequivocally be predicted from the MIC value determined in vitro.<\/jats:p>","DOI":"10.1111\/j.1439-0507.1996.tb00528.x","type":"journal-article","created":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T16:35:32Z","timestamp":1240590932000},"page":"47-50","source":"Crossref","is-referenced-by-count":1,"title":["Vergleich von drei Antimykotika\u2010Empfindlichkeitspr\u00fcfungs\u2010Methoden f\u00fcr die In\u2010vitro\u2010Testung von <i>Candida<\/i>\u2010Isolaten von Patienten mit HIV\u2010Infektion"],"prefix":"10.1111","volume":"39","author":[{"given":"M.","family":"Ruhnke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Schmidt\u2010Westhausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Trautmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","volume-title":"Reference method for broth dilution antifungal susceptibility testing for yeasts; proposed standard M27\u2010P","author":"National Committee for Clinical Laboratory Standards","year":"1992"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.30.12.3138-3145.1992"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.33.3.535-540.1995"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.32.9.2099-2102.1994"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.32.9.2092-2098.1994"},{"key":"e_1_2_1_7_2","unstructured":"Troke P. F. B.Dupont A.Espinel\u2010Ingroff G. S.Kobayashi J.M\u00fcller M. A.Pfaller M. G.Rinaldi T. J.Walsh andD. W.Warrock1992.Standardised susceptibility testing of fluconazole: a nine centre international collaborative study. Program Abstr. 32nd Intersci. Conf. Antimicrob. Agents Chemother. abstr. 1596."},{"key":"e_1_2_1_8_2","volume-title":"Etest technical guide No. 4b Antifungal Susceptibility Testing of Yeasts","author":"AB BIODISK","year":"1994"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(94)90034-5"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0507.1996.tb00528.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1439-0507.1996.tb00528.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T05:56:34Z","timestamp":1695707794000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.1996.tb00528.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,10]]},"references-count":8,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[1996,10]]}},"alternative-id":["10.1111\/j.1439-0507.1996.tb00528.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1439-0507.1996.tb00528.x","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,10]]}}}